Inventor · disambiguated record
Heinz Hillen
Also filed as: HILLEN HEINZ
30 granted patents·13 pending applications·253 citations·filing 1986–2022
96Inventor score
Top patents by PatentIndex Score
43 records- 0193US7902328B2Amyloid β(1-42) oligomers, derivatives thereof and antibodies thereto, methods of preparation thereof and use thereofABBOTT GMBH & CO KG·Filed 2004·Granted Mar 8, 2011·46 cites·27 claims
- 0290US8987419B2Amyloid-beta binding proteinsBARGHORN STEFAN·Filed 2011·Granted Mar 24, 2015·15 cites·11 claims
- 0390US8691224B2Anti-Aβ globulomer 5F7 antibodiesBARGHORN STEFAN·Filed 2006·Granted Apr 8, 2014·14 cites·16 claims
- 0488US8263558B2Methods of preparation of recombinant forms of human beta-amyloid protein and uses of these proteinsHOLZMAN THOMAS F·Filed 2006·Granted Sep 11, 2012·23 cites·14 claims
- 0587US9359430B2Abeta conformer selective anti-Abeta globulomer monoclonal antibodiesABBVIE INC·Filed 2013·Granted Jun 7, 2016·4 cites·7 claims
- 0686US9394360B2Aβ conformer selective anti-Aβ globulomer monoclonal antibodiesABBVIE DEUTSCHLAND·Filed 2014·Granted Jul 19, 2016·6 cites·2 claims
- 0785US10323084B2Monoclonal antibodies against amyloid beta protein and uses thereofABBVIE INC·Filed 2017·Granted Jun 18, 2019·3 cites·16 claims
- 0885US8497072B2Amyloid-beta globulomer antibodiesHILLEN HEINZ·Filed 2006·Granted Jul 30, 2013·6 cites·18 claims
- 0984US5344915AProteins and the preparation thereofBASF AG·Filed 1990·Granted Sep 6, 1994·55 cites·3 claims
- 1083US9062101B2Amyloid-beta binding proteinsBARGHORN STEFAN·Filed 2011·Granted Jun 23, 2015·6 cites·43 claims
- 1180US8455626B2Aβ conformer selective anti-aβ globulomer monoclonal antibodiesBARGHORN STEFAN·Filed 2007·Granted Jun 4, 2013·4 cites·13 claims
- 1280US6683055B1Low molecular weight inhibitors of complement proteasesBASF AG·Filed 2000·Granted Jan 27, 2004·17 cites·16 claims
- 1379US10464976B2Amyloid β(1-42) oligomers, derivatives thereof and antibodies thereto, methods of preparation thereof and use thereofABBVIE DEUTSCHLAND·Filed 2015·Granted Nov 5, 2019·2 cites·31 claims
- 1477US10047121B2Amyloid-beta binding proteinsABBVIE DEUTSCHLAND·Filed 2015·Granted Aug 14, 2018·2 cites·18 claims
- 1576US9176150B2Amyloid beta(1-42) oligomers, derivatives thereof and antibodies thereto, methods of preparation thereof and use thereofHILLEN HEINZ·Filed 2011·Granted Nov 3, 2015·3 cites·12 claims
- 1676US2022017607A1Monoclonal antibodies against amyloid beta protein and uses thereofABBVIE INC·Filed 2021·Application pending·0 cites
- 1775US9951125B2Aβ conformer selective anti-Aβ globulomer monoclonal antibodiesABBVIE INC·Filed 2016·Granted Apr 24, 2018·1 cites·19 claims
- 1874US10538581B2Anti-Aβ globulomer 4D10 antibodiesABBVIE INC·Filed 2016·Granted Jan 21, 2020·1 cites·17 claims
- 1971US5180811AProteins having a tnf action comprising tnf-fibromectin fusion proteinBASF AG·Filed 1988·Granted Jan 19, 1993·24 cites·2 claims
- 2070US8895004B2Method for the treatment of amyloidosesNIMMRICH VOLKER·Filed 2008·Granted Nov 25, 2014·2 cites·3 claims
- 2169US2024075114A1IMMUNOGENIC PRODUCTS BASED ON MUTEIN AMYLOID beta (Abeta) AMINO ACID SEQUENCES AND USES THEREOFABBVIE DEUTSCHLAND·Filed 2022·Application pending·0 cites
- 2264US2010209346A1Amyloid beta(1-42) oligomers, derivatives thereof and antibodies thereto, methods of preparation thereof and use thereofHILLEN HEINZ·Filed 2009·Application pending·0 cites
- 2364US2015071915A1Monoclonal antibodies against amyloid beta protein and uses thereofABBVIE INC·Filed 2014·Application pending·0 cites
- 2459US9540432B2Anti-Aβ globulomer 7C6 antibodiesABBVIE INC·Filed 2013·Granted Jan 10, 2017·0 cites·14 claims
- 2558US10208109B2Monoclonal antibodies against amyloid beta protein and uses thereofHILLEN HEINZ·Filed 2011·Granted Feb 19, 2019·0 cites·20 claims
- 2658US2016159891A1Monoclonal antibodies against amyloid beta protein and uses thereofABBVIE INC·Filed 2016·Application pending·0 cites
- 2757US8877190B2Aβ conformer selective anti-Aβ globulomer monoclonal antibodiesBARGHORN STEFAN·Filed 2011·Granted Nov 4, 2014·0 cites·5 claims
- 2853US2018094049A1Amyloid-beta binding proteinsABBVIE DEUTSCHLAND·Filed 2017·Application pending·0 cites
- 2952US2010173828A1Aß(X - 38 .. 43) oligomers, and processes, compositions, and uses thereofABBOTT GMBH & CO KG·Filed 2009·Application pending·0 cites
- 3050US9822171B2Amyloid-beta binding proteinsABBVIE DEUTSCHLAND·Filed 2015·Granted Nov 21, 2017·0 cites·15 claims
- 3149US2011092445A1Amyloid ß peptide analogues, oligomers thereof, processes for preparing and composi-tions comprising said analogues or oligomers, and their usesABBOTT LAB·Filed 2009·Application pending·0 cites
- 3249US2009175847A1Humanized antibodies to ab (20-42) globulomer and uses thereofABBOTT LAB·Filed 2008·Application pending·0 cites
- 3349US2009232801A1Humanized Antibodies Which Bind To AB (1-42) Globulomer And Uses ThereofABBOTT LAB·Filed 2008·Application pending·0 cites
- 3448US4736020APurification of hTNFBASF AG·Filed 1986·Granted Apr 5, 1988·9 cites·2 claims
- 3544US2015079096A1Method for the treatment of amyloidosesABBVIE DEUTSCHLAND·Filed 2014·Application pending·0 cites
- 3643US2009035295A1Screening Method, Process for Purifying of Non-Diffusible A-Beta Oligomers, Selective Antibodies Against Said Non-Diffusible a-Beta Oligomers and a Process for Manufacturing of Said AntibodiesABBOTT GMGH & CO KG·Filed 2006·Application pending·0 cites
- 3741US6358983B1Heterocyclically substituted α-hydroxycarboxylic acid derivatives, method for producing the same and their use as endothelin receptor antagonistsABBOTT LAB·Filed 1998·Granted Mar 19, 2002·4 cites·5 claims
- 3841US2016000891A1IMMUNOGENIC PRODUCTS BASED ON MUTEIN AMYLOID beta (Abeta) AMINO ACID SEQUENCES AND USES THEREOFABBVIE DEUTSCHLAND·Filed 2015·Application pending·0 cites
- 3936US6066502AEndothelin converting enzyme (ECE)BASF AG·Filed 1994·Granted May 23, 2000·2 cites·4 claims
- 4034US6469056B1Pharmaceutically active compounds, their preparation and use as ECE-inhibitorsABBOTT LAB·Filed 1998·Granted Oct 22, 2002·3 cites·10 claims
- 4132US5759541ARecombinant fibrinogenases, the preparation and use thereofBASF AG·Filed 1996·Granted Jun 2, 1998·1 cites·28 claims
- 4229US6610691B1Carboxylic acid derivatives, their production and useBASF AG·Filed 1997·Granted Aug 26, 2003·0 cites·15 claims
- 4327US5157106AN-terminal deletions of lymphotoxin, their preparation and useBASF AG·Filed 1987·Granted Oct 20, 1992·0 cites·3 claims
Join the waitlist — get patent alerts
Get an alert when Heinz Hillen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →